Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Asset disposition
Quarterly results
CC transcript
ACADIA PHARMACEUTICALS INC (ACAD) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 KIM AUSTIN D. (EVP,General Counsel, Secretary) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 16,369 shares @ $21.96, valued at $359.5k
Exercised 36,174 restricted stock units @ $0
10/06/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Exercised 103,999 shares @ $0
Sold 51,563 shares @ $21.96, valued at $1.1M
Exercised 103,999 restricted stock units @ $0
08/23/2023 4 Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $28.997, valued at $290k
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 8-K Quarterly results
Docs: "Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview - 2Q23 DAYBUE™ net product sales of $23.2 million - 2Q23 NUPLAZID® net product sales of $142.0 million - Expanded licensing agreement for trofinetide includes ex-North American rights SAN DIEGO, CA, August 2, 2023"
07/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2023 8-K Quarterly results
07/14/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 16,498 shares @ $25, valued at $412.5k
Sold 55,104 shares @ $25.0517, valued at $1.4M
07/13/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 4 Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 2,000 shares @ $24.15, valued at $48.3k
06/12/2023 4 Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 974 shares @ $25.02, valued at $24.4k
Exercised 1,893 restricted stock units @ $0
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Granted 13,304 shares @ $0
Granted 22,090 options to buy @ $23.9, valued at $528k
05/24/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 26.5% stake in ACADIA Pharmaceuticals Inc.
05/24/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Bought 7,645 shares @ $24.4604, valued at $187k
Bought 82,148 shares @ $24.4604, valued at $2M
Bought 3,781 shares @ $24.8, valued at $93.8k
Bought 40,632 shares @ $24.8, valued at $1M
Bought 10,858 shares @ $25.3302, valued at $275k
Bought 116,672 shares @ $25.3302, valued at $3M
Bought 6,941 shares @ $25.54, valued at $177.3k
Bought 74,582 shares @ $25.54, valued at $1.9M
Bought 20,304 shares @ $25.2723, valued at $513.1k
Bought 218,171 shares @ $25.2723, valued at $5.5M
Bought 2,688 shares @ $25.5138, valued at $68.6k
05/19/2023 4 Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 5,947 shares @ $22.5, valued at $133.8k
Exercised 5,947 restricted stock units @ $0
05/19/2023 4 Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 15,310 shares @ $22.5, valued at $344.5k
Exercised 14,869 restricted stock units @ $0
05/19/2023 4 Teehan Brendan (EVP, COO, Head of Commercial) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 14,869 shares @ $22.5, valued at $334.6k
Exercised 14,869 restricted stock units @ $0
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
Docs: "Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview - 1Q23 NUPLAZID® net sales of $118.5 million - Announced the U.S. FDA Approval of DAYBUE™ for the Treatment of Rett Syndrome in Adult and Pediatric Patients Two Years of Age and Older on March 10, 2023 - Announced DAYBUE Availability on April 17, 2023 SAN DIEGO, CA, May 8, 2023"
05/03/2023 4 Teehan Brendan (EVP, COO, Head of Commercial) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Granted 89,936 options to buy @ $21.75, valued at $2M
Granted 27,259 restricted stock units @ $0
05/03/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Granted 295,503 options to buy @ $21.75, valued at $6.4M
Granted 89,564 restricted stock units @ $0
05/03/2023 4 Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Granted 89,936 options to buy @ $21.75, valued at $2M
Granted 27,259 restricted stock units @ $0
05/03/2023 4 KIM AUSTIN D. (EVP,General Counsel, Secretary) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Granted 59,957 options to buy @ $21.75, valued at $1.3M
Granted 18,172 restricted stock units @ $0
05/03/2023 4 Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Granted 17,131 options to buy @ $21.75, valued at $372.6k
Granted 10,384 restricted stock units @ $0
05/02/2023 4 KIM AUSTIN D. (EVP,General Counsel, Secretary) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 917 shares @ $21.18, valued at $19.4k
Exercised 3,005 restricted stock units @ $0
05/02/2023 4 Teehan Brendan (EVP, COO, Head of Commercial) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 548 shares @ $21.18, valued at $11.6k
Exercised 1,567 restricted stock units @ $0
05/02/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 7,806 shares @ $21.18, valued at $165.3k
Exercised 15,625 restricted stock units @ $0
03/13/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
02/27/2023 4 Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 350 shares @ $18.78, valued at $6.6k
Exercised 840 restricted stock units @ $0
02/27/2023 4 Schneyer Mark C. (EVP, CFO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 577 shares @ $18.78, valued at $10.8k
Exercised 1,353 restricted stock units @ $0
02/27/2023 4 DAVIS STEPHEN (CEO) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 3,851 shares @ $18.78, valued at $72.3k
Exercised 10,945 restricted stock units @ $0
02/27/2023 4 KIM AUSTIN D. (EVP,General Counsel, Secretary) has filed a Form 4 on ACADIA PHARMACEUTICALS INC
Txns: Sold 803 shares @ $18.78, valued at $15.1k
Exercised 2,214 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy